HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wojciech Jurczak Selected Research

ibritumomab tiuxetan (Zevalin)

11/2019Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
1/2015The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation.
1/2012[Hematological toxicity of radioimmunotherpy with 90Y Ibritumomab].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wojciech Jurczak Research Topics

Disease

33Lymphoma (Lymphomas)
04/2024 - 08/2003
26Neoplasms (Cancer)
02/2024 - 01/2005
25B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2024 - 01/2018
21Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2023 - 09/2010
17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2023 - 01/2005
15Disease Progression
08/2023 - 10/2013
15Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 01/2007
14Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021 - 08/2003
12B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 01/2012
11Neutropenia
11/2023 - 09/2015
10Infections
07/2023 - 08/2015
9Atrial Fibrillation
11/2023 - 10/2020
9Hemorrhage
10/2023 - 08/2015
7Hypertension (High Blood Pressure)
11/2023 - 11/2014
6Waldenstrom Macroglobulinemia (Macroglobulinemia)
02/2024 - 10/2020
6Diarrhea
11/2023 - 08/2015
5Pneumonia (Pneumonitis)
11/2023 - 01/2017
5Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 05/2017
5Thrombocytopenia (Thrombopenia)
12/2021 - 09/2015
4Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2021 - 11/2018
4Rheumatoid Arthritis
12/2019 - 08/2017
4Hodgkin Disease (Hodgkin's Disease)
01/2019 - 09/2015
3Spasm (Spasms)
11/2023 - 10/2020
3Headache (Headaches)
01/2023 - 01/2018
3Leukemia
07/2020 - 01/2018
3Heart Failure
12/2019 - 05/2017
3Cardiotoxicity
01/2019 - 11/2014
3Febrile Neutropenia
01/2018 - 01/2015
2Fever (Fevers)
01/2022 - 01/2017
2Contusions
10/2020 - 11/2018
2Left Ventricular Dysfunction
12/2019 - 11/2014
2Lymphadenopathy
01/2017 - 01/2007
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
08/2015 - 01/2013
1Lymphocytosis
07/2023
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2023
1Back Pain (Backache)
01/2023
1Cough
01/2023
1Dyspepsia (Indigestion)
01/2023
1Arthralgia (Joint Pain)
01/2023
1Paraproteinemias (Monoclonal Gammopathy)
01/2023
1Urinary Tract Infections (Urinary Tract Infection)
01/2023
1Skin Neoplasms (Skin Cancer)
12/2022
1Sepsis (Septicemia)
01/2022
1Rare Diseases (Rare Disease)
12/2021

Drug/Important Bio-Agent (IBA)

28Rituximab (Mabthera)FDA Link
04/2024 - 01/2007
26Agammaglobulinaemia Tyrosine KinaseIBA
05/2024 - 08/2013
26ibrutinibIBA
05/2024 - 08/2013
14acalabrutinibIBA
05/2024 - 01/2018
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2024 - 10/2014
13Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024 - 10/2014
13Prednisone (Sone)FDA LinkGeneric
04/2024 - 10/2014
12Vincristine (Oncovin)FDA LinkGeneric
04/2024 - 10/2014
9zanubrutinibIBA
02/2024 - 10/2020
8Lenalidomide (CC 5013)FDA Link
08/2023 - 10/2014
8Monoclonal AntibodiesIBA
01/2021 - 01/2006
6Bendamustine HydrochlorideFDA Link
01/2022 - 01/2017
6Biosimilar PharmaceuticalsIBA
01/2021 - 08/2017
5tafasitamabIBA
08/2023 - 01/2020
4venetoclaxIBA
07/2023 - 06/2016
4pirtobrutinibIBA
07/2023 - 01/2021
4CT-P10IBA
01/2022 - 08/2017
4Inosine Triphosphate (ITP)IBA
12/2021 - 11/2018
4AnthracyclinesIBA
12/2019 - 11/2014
3obinutuzumabIBA
01/2022 - 01/2018
3Chlorambucil (Leukeran)FDA Link
01/2022 - 01/2018
3avatrombopagIBA
01/2021 - 11/2018
3idelalisibIBA
01/2020 - 01/2017
3ibritumomab tiuxetan (Zevalin)FDA Link
11/2019 - 01/2012
3temsirolimusFDA Link
01/2018 - 02/2016
3Immunoconjugates (Immunoconjugate)IBA
01/2018 - 01/2007
3Cytarabine (Cytosar-U)FDA LinkGeneric
04/2015 - 01/2013
2Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2021
2parsaclisibIBA
12/2023 - 08/2023
2umbralisibIBA
12/2021 - 01/2021
2NivolumabIBA
01/2021 - 02/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 09/2020
2Etoposide (VP 16)FDA LinkGeneric
06/2019 - 01/2019
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2019 - 01/2018
2Thrombopoietin ReceptorsIBA
01/2019 - 11/2018
2Brentuximab VedotinIBA
11/2018 - 01/2018
2YttriumIBA
01/2007 - 01/2007
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
04/2024
1Proteins (Proteins, Gene)FDA Link
01/2023
1ceralasertibIBA
01/2023
1Immunoglobulin M (IgM)IBA
01/2023
16-bromo-2-naphthyl sulfate (BNS)IBA
07/2022
1polatuzumab vedotinIBA
01/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2021
1Transaminases (Aminotransferases)IBA
12/2021

Therapy/Procedure

50Therapeutics
04/2024 - 01/2006
17Drug Therapy (Chemotherapy)
04/2024 - 08/2003
7Stem Cell Transplantation
01/2021 - 08/2003
7Radioimmunotherapy
05/2020 - 01/2006
3Aftercare (After-Treatment)
12/2023 - 01/2008
3Radiotherapy
04/2015 - 01/2007
2Immunotherapy
08/2023 - 02/2008
2Intravenous Infusions
01/2021 - 08/2017
2VAP-cyclo protocol
01/2018 - 10/2013
1Duration of Therapy
07/2023
1Drug Tapering
01/2022